CAM Advised Middle Eastern Sovereign Fund On Its Investment In Micro Life Sciences

August 11, 2025

Cyril Amarchand Mangaldas (CAM) advised Middle Eastern Sovereign Fund on its investment of $200 Million for an approx. 3% stake in Micro Life Sciences, one of India’s leading medical device companies.

The transaction is subject to approval by the Competition Commission of India (CCI).

The transaction team included Vandana Sekhri, Arun Sadhanand Prabhu, Poornima Singh, Radhika Shukla, Sudarshan Srikanth, Drumil Sanghvi, Rishi Rathod.

Strategic inputs and guidance was provided by Indranil Deshmukh, Shaneen Parikh, Gokul Ranjan.

Due Diligence Team: Vandana Sekhri, Siddharth Vedula, Dhrumil Sanghvi, Lokit Khurana, Kabeer Jay, Bhavya Arya, Karthik Subramaniam, Kanishka Iyer.

Arun Sadhanand Prabhu, Bhavya Arya, Dhrumil Sanghvi, Gokul Ranjan, Indranil Deshmukh, Kabeer Jay, Kanishka Iyer, Karthik Subramaniam, Lokit Khurana, Poornima Singh, Radhika Shukla, Rishi Rathod, Shaneen Parikh, Siddharth Vedula, Sudarshan Srikanth, Vandana Sekhri

Healthcare

Private Equity

The deal reporting on this platform is based on the information received from law firms, and therefore, some details may be missing/incomplete. If your firm has not been credited for this deal, write to us at connect@thedealmatter.com mentioning your firm’s name, lawyers involved (including designation) and client represented.